Geistlich Pharma
-
Biologics
Geistlich announces the dramatic expansion of their allograft portfolio – vallos® sets the pace for regeneration
PRINCETON, N.J., March 16, 2023 /PRNewswire/ — Geistlich Pharma North America Inc. is pleased to introduce a growing variety of vallos® allograft configurations…
Read More » -
Recon
Active Implants Enters Partnership with Geistlich Pharma AG for NUsurface® Meniscus Prosthesis
World’s First Artificial Meniscus Prosthesis is Now Available in Switzerland September 6, 2021 MEMPHIS, Tenn.–(BUSINESS WIRE)–Active Implants LLC, a company…
Read More »